Dr. Kristine Rinn, MD
Claim this profileCancer Care Northwest
Studies Breast Cancer
Studies Pancreatic Cancer
7 reported clinical trials
13 drugs studied
Area of expertise
1Breast Cancer
Stage IV
ER positive
HER2 negative
2Pancreatic Cancer
Stage IV
Stage III
Affiliated Hospitals
Clinical Trials Kristine Rinn, MD is currently running
Elacestrant
for Breast Cancer
The primary goal of this study is to evaluate the effectiveness of elacestrant versus standard endocrine therapy in participants with node-positive, Estrogen Receptor-positive (ER+), Human Epidermal Growth Factor-2 negative (HER2-) early breast cancer with high risk of recurrence.
Recruiting2 awards Phase 33 criteria
Elacestrant Combinations
for Breast Cancer
This is a multicenter, Phase 1b/2 trial in participants with estrogen receptor positive/human epidermal growth factor receptor 2 negative (ER+/HER2-) advanced/metastatic breast cancer. The phase 1b part of the trial will determine the recommended Phase 2 dose (RP2D) of elacestrant when administered in combination with alpelisib, everolimus, palbociclib, capivasertib, and ribociclib. The Phase 2 part of the trial will evaluate the efficacy and safety of the various combinations.
Recruiting1 award Phase 1 & 2
More about Kristine Rinn, MD
Clinical Trial Related1 year of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Kristine Rinn, MD has experience with
- Elacestrant
- Abemaciclib
- Enobosarm
- Alpelisib
- Everolimus
- Palbociclib
Breakdown of trials Kristine Rinn, MD has run
Breast Cancer
Pancreatic Cancer
Breast cancer
Kennedy's Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kristine Rinn, MD specialize in?
Kristine Rinn, MD focuses on Breast Cancer and Pancreatic Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are ER positive.
Is Kristine Rinn, MD currently recruiting for clinical trials?
Yes, Kristine Rinn, MD is currently recruiting for 3 clinical trials in Spokane Valley Washington. If you're interested in participating, you should apply.
Are there any treatments that Kristine Rinn, MD has studied deeply?
Yes, Kristine Rinn, MD has studied treatments such as Elacestrant, Abemaciclib, Enobosarm.
What is the best way to schedule an appointment with Kristine Rinn, MD?
Apply for one of the trials that Kristine Rinn, MD is conducting.
What is the office address of Kristine Rinn, MD?
The office of Kristine Rinn, MD is located at: Cancer Care Northwest, Spokane Valley, Washington 99216 United States. This is the address for their practice at the Cancer Care Northwest.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.